Table 7.

Anti-fracture efficacy of drugs in men. All the papers mentioned are of evidence A.

	Anti-Fracture Efficacy in Men
Antiresorptive Agents	Vertebral	Hip	Non Vertebral
Alendronate -10 mg/daily -70 mg/weekly	A [113]
Risedronate -5 mg/daily -35 mg/weekly	A [124]	A [115]	A [124]
Zoledronate -5 mg/yearly (EV)	A [112]
Denosumab -60 mg every 6 months (SQ)	A [125]
Anabolic agents
Teriparatide	A [126]